Rancho BioSciences Honored as One of the Fortune Best Workplaces in BioPharma 2023
SAN DIEGO, CA / ACCESSWIRE / November 8, 2023 / Rancho BioSciences, the leading Data Science Services company based in...
Pharmaceutical
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte’s Technology Fast 500(TM) for Third Consecutive Year
Ranked 118th Fastest Growing Company in North AmericaRanked 23rd Fastest Growing Life Sciences CompanyDENVER, CO / ACCESSWIRE / November 8,...
Jaguar Health to Hold Investor Webcast Tuesday, November 14th at 8:30 AM Eastern Regarding Q3 2023 Financials & Corporate Updates
Click here to register for November 14 investor webcastCompany plans to file its Earnings Report on November 14, 2023 on...
As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
Company Introduces Multimedia Resources to Bring Awareness of SADLAVAL, QC / ACCESSWIRE / November 8, 2023 / As daylight saving...
Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape
ORLANDO, FL / ACCESSWIRE / November 8, 2023 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that it has signed a supplier...
Moderna Highlights its Digital and AI Strategy and Progress at Second Digital Investor Event
The Company demonstrates how its integrated Artificial Intelligence ecosystem accelerates innovation at scale and creates value across the enterpriseModerna to...
New Real-World Data Show TREMFYA® (guselkumab) Was Associated With Clinically Meaningful Improvements in Patient-Reported Outcomes for Adults Living With Active Psoriatic Arthritis
People living with treatment-resistant active psoriatic arthritis reported meaningful improvements in pain, physical function and fatigue on guselkumab through six...
Parexel Named 2023 Healthcare Businesswomen’s Association ACE Award Honoree
Award reflects company’s ongoing commitment to advancing women in leadership and maintaining a gender-equitable cultureDURHAM, N.C., Nov. 08, 2023 (GLOBE NEWSWIRE)...
Yield10 Bioscience to Announce Third Quarter 2023 Financial Results and Host a Conference Call on Tuesday, November 14, 2023
WOBURN, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company,...
Gracell Biotechnologies Wins Overall Immunology Solution of the Year by BioTech Breakthrough Awards Program
Third annual BioTech Breakthrough Award recognizes excellence in life science and biotechnology solutions, services and companies GC012F, a FasTCAR-enabled autologous...
Eagle Pharmaceuticals to Host Third Quarter 2023 Financial Results on November 9, 2023
WOODCLIFF LAKE, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced...
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Third Quarter 2023 Financial Results on November 14, 2023
FREDERICK, Md., Nov. 08, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
Government Agencies Emphasize the Importance of Decentralized Methodologies for Future of Clinical Research
Decentralized Trials & Research Alliance brings together Global Leaders for its Annual Meeting SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE)...
Organovo Highlights FXR314 Combination Therapy Potential and Plan
SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), a clinical stage biotechnology company that is...
Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
CIRM-Funded Programs to Receive Access to Avid’s Suite of World-Class CGT CDMO Services to Support Clinical Development ActivitiesTUSTIN, Calif., Nov....
Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
Phase 1b Study of NXP800 in Patients with Platinum Resistant, ARID1a-Mutated Ovarian Carcinoma is Ongoing Initiated the Phase 1a Dose...
Collegium to Participate in Upcoming Investor Conferences
STOUGHTON, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to...
Ocular Therapeutix™ to Present at Three Upcoming Investor Conferences
BEDFORD, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development,...
Icosavax to Participate in the Jefferies London Healthcare Conference
SEATTLE, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP)...
vTv Therapeutics to Participate at the Stifel 2023 Healthcare Conference
HIGH POINT, N.C., Nov. 08, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused...